Global Home Infusion Therapy Market Is Expected to Reach USD 43.62 Billion by 2027 : Fior Markets

Home Infusion Therapy Market by Product (Intravenous Sets, IV Cannulas, Infusion Pumps, Needleless Connectors), Application (Parenteral Nutrition, Enteral Nutrition, Chemotherapy, Hydration Therapy, Specialty Pharmaceuticals, Endocrinology, Anti-Infective, Others), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027

Pune, INDIA


Newark, NJ, Sept. 15, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global home infusion therapy market is expected to grow from USD 25.2 billion in 2019 to USD 43.62 billion by 2027, at a CAGR of 7.1% during the forecast period 2020-2027.

Some important factors drive the growth of the market such as cost-effectiveness, convenience, rising geriatric population with lower mobility profile, increasing preference for home care, rapid technological advancements

Home infusion therapy is a medical procedure that involves the subcutaneous or intravenous administration of drugs or other biologicals to an individual living at home. The components required to perform home infusion therapy are supplies (tubing & catheters, for example), equipment (pump for instance), and the drug (antivirals or immune globulin, for example). Similarly, nursing resources are required to teach and advise the patient and caregivers about the safe administering of in-house infusion medications. Visiting nurses also play a significant role in home infusion. Usually, nurses teach the patient or caregiver to self-administer the drug, inform about side effects and treatment goals, and revisit periodically to determine the site of the infusion and make adjustments in dressing.

With the outbreak of a global pandemic, many have faced salary cuts and job losses. Covid-19 has become a threat to the entire world's economy and has negatively impacted all kinds of markets, including the home infusion therapy market. With less disposable income and broken supply chains, the market's growth is expected to slow down. Also, risks associated with the erratic operation of infusion devices combined with a lack of reimbursement policies can impede the growth of the global home infusion therapy market over the forecast timeframe.

DOWNLOAD FREE SAMPLE REPORT AT https://www.fiormarkets.com/report-detail/418851/request-sample

Key players operating in the global home infusion therapy market include B. Braun Melsungen AG, JMS Co. Ltd., Baxter, Smiths Medical, Caesarea Medical Electronics, Fresenius Kabi, Eli Lilly and Company, CareFusion Corporation, Terumo Corporation, and ICU Medical, Inc. among others. To gain a significant market share in the global home infusion therapy market, the key players are now focusing on adopting strategies such as product innovations, mergers & acquisitions, recent developments, joint ventures, collaborations, and partnerships. B. Braun Melsungen AG and ICU Medical, Inc. are some of the biggest manufacturers and suppliers of home infusion therapy devices in the global market.

  • For instance, on April 2020, B. Braun Melsungen reported that it has been authorized by the US Food and Drug Administration (FDA) with an Emergency Use Authorization (EUA) of Braun's Perfusor, Space Syringe Infusion Pump, Space Volumetric Infusion Pump, Infusomat, and Outlook ES Pump systems for use in the delivery of nebulized drugs to treat patients of all ages suspected of having COVID-19 and to minimize the liability of healthcare providers (HCP) to these patients during Coronavirus pandemic.
  • In October 2018, Baxter International partnered with the American Society for Parenteral and Enteral Nutrition (ASPEN). The partnership has resulted in the launch of a SmartPN tool, which helps to minimize clinical malnutrition. This has expanded demand in the market and also assisted growth in the industry.

Infusion pumps dominated the market and held the largest market share of 30.6% in the year 2019

The product segment comprises of intravenous sets, IV cannulas, infusion pumps, and needleless connectors. Infusion pumps dominated the market and held the largest market share of 30.6% in the year 2019. This is primarily due to the reason that infusion pumps are hugely preferred for the delivery of medication & nutrients. The availability of a variety of products like a syringe, enteral, peristaltic pumps, and multichannel further boosts the segment growth. The increasing demand for ambulatory pumps & syringes owing to the growing preference for home healthcare is expected to fuel the growth of this segment.

Anti-infective dominated the market and valued at USD 3.7 billion in the year 2019

Based on application, the global market has been segmented into parenteral nutrition, enteral nutrition, chemotherapy, hydration therapy, specialty pharmaceuticals, endocrinology, anti-infective, and others. Anti-infective dominated the market and valued at USD 3.7 billion in the year 2019. The large share of this segment can be attributed to the large number of operations performed for the administration of antibiotic & antifungal drugs. It also reduces the risk of exposure to other hospital-acquired infections.

Browse full report with TOC at https://www.fiormarkets.com/report/home-infusion-therapy-market-by-product-intravenous-sets-418851.html

Regional Segment Analysis of the Home Infusion Therapy Market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan India, Rest of APAC)
  • South America (Brazil and Rest of South America) 
  • Middle East and Africa (UAE, South Africa, Rest of MEA)

On the basis of geography, the global home infusion therapy market has been classified into North America, Europe, South America, Asia Pacific, and Middle East and Africa. The North America region accounted for the major market share of 48.7% in the year 2019 and is anticipated to grow throughout the projected period. The large share of this segment is attributed to key factors such as the presence of key industry players, advanced healthcare infrastructure, rising R&D activities in the region, increasing adoption of new infusion pump technology, growing need for long-term therapy, the introduction of alternate healthcare settings & home infusion services, enhanced patient mobility, and growing preference of home care settings because of low cost. On the other hand, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period from 2020-2027. This growth is due to factors like the booming prevalence of chronic diseases, growing patient awareness about the benefits of home infusion therapy as compared to in-hospital procedures and the rising prevalence of diabetes.

Request for Customization: https://www.fiormarkets.com/enquiry/request-customization/418851

About the report: 

The global home infusion therapy market is analyzed on the basis of value (USD Billion). All the segments have been analyzed on a global, regional, and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers an in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter's five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.

For Instant Purchase: https://www.fiormarkets.com/checkout.html?reportid=418851&type=single

Customization of the Report:

The report can be customized as per client requirements. For further queries, you can contact us on sales@fiormarkets.com or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

About Fior Markets

Fior Markets is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients’ objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports. Fior Markets deploys a wide range of regional and global market intelligence research reports including industries like technology, pharmaceutical, consumer goods, food and beverages, chemicals, media, materials and many others. Our Strategic Intelligence capabilities are purposely planned to boost your business extension and elucidate the vigor of diverse industry. We hold distinguished units of highly expert analysts and consultants according to their respective domains. The global market research reports we provide involve both qualitative and quantitative analysis of current market scenario as per the geographical regions segregated and comprehensive performance in different regions with global approach. In addition, our syndicated research reports offer a packaged guide to keep companies abreast of the upcoming major restyle in their domains. Fior Markets facilitates clients with research analysis that are customized to their exact requirements, specifications and challenges, whether it is comprehensive desk research, survey work, composition of multiple methods, in-detailed interviewing or competitive intelligence. Our research experts are experienced in matching the exact personnel and methodology to your business need.

Contact Us

Avinash D
Head of Business Development
Phone: +1-201-465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com






To Read Top Industries Reports, Visit our Affiliated Website: https://www.marketquest.biz

Related Reports

Non-Invasive Brain Trauma Monitoring Devices Market - https://www.fiormarkets.com/report/non-invasive-brain-trauma-monitoring-devices-market-by-product-418783.html
Peripherally Inserted Central Catheters Market - https://www.fiormarkets.com/report/peripherally-inserted-central-catheters-market-by-product-type-418784.html
Super Resolution Microscopes Market - https://www.fiormarkets.com/report/super-resolution-microscopes-market-by-technology-stimulated-emission-418785.html
Uterine Fibroid Treatment Device Market - https://www.fiormarkets.com/report/uterine-fibroid-treatment-device-market-by-technology-ablation-418786.html